IU Team Continuing Bone Study in Space

Posted: Updated:
The official mission patch for the group. (image courtesy of Indiana University) The official mission patch for the group. (image courtesy of Indiana University)
INDIANAPOLIS -

A team of researchers from the Indiana University School of Medicine in Indianapolis will Tuesday begin the second phase of an experiment heading to space. The research project will study the effect of spaceflight on osteoblast cells, which are essential to bone development, as well as the effects of certain drugs on bone healing. Melissa Kacena, director of basic and translational research at the school, is leading the effort in collaboration with NASA and the U.S. Army.

The first phase of the project took place in 2017, when the team sent mice into space and tested them using bone-healing therapies in weightlessness. In an interview with Inside INdiana Business Reporter Mary-Rachel Redman, Kacena said the effort is able to continue due to the success of the first phase.

"Most of the time I would've said it's a once-in-a-lifetime opportunity so clearly, for myself and one of my students, its a twice-in-a-lifetime opportunity," said Kacena. "I think that NASA and the peer review system have validated it and the Army came to us and approached us and so they thought that the work we do here in Indiana is really world renowned, that we're doing some of the best bone healing work and that we're the right people to tackle the problem and help them out."

The cells are set to launch into space July 21, heading for the International Space Station. There, astronauts will culture the cells to help researchers see the effects of an FDA-approved bone-healing drug, as well as a new drug identified by Kacena. The university says sending the cells into space ensures the drugs can be tested without any of the natural healing that weight-bearing can have on broken bones and damaged cells. 

"When we walk, we load our bones and this is really important in both keeping your bone mass and in the bone healing process. In spaceflight, you don't have that and therefore, we can really assess how well a drug will work in humans here on Earth because we get rid of that."

In the first phase of the project, the drug was tested on mice that had undergone an orthopaedic surgery. IU says testing osteoblast cells will give researchers a better understanding on how the drug will work on humans. Kacena says, if the drugs work in space, then they'll work anywhere.

You can read more about the first phase of the project from our Life Sciences INdiana e-newsletter by clicking here.

Kacena will monitor the experiment from the Kennedy Space Center and also ensure that ground control samples are treated as identically as possible to the spaceflight samples. When the cells return to Earth, they will be fully analyzed. 

The team of researchers includes undergraduate students, medical students and post-doctoral researchers. Kacena says the ultimate goal is to gain FDA approval and begin treating patients with the bone-healing therapy, but those results could still be 15-20 years away. 

  • Perspectives

    • Richardson is a practice lead with Centric Consulting.

      How to Create Consistent and Positive Customer Experiences with Your Brand

      Everyone knows that keeping the consumer happy is the first priority. The importance of considering the customer’s experience in all areas of engaging with your business, not just customer service is becoming even more clear. I’m seeing an increasing number of my peers in the marketing world take ownership of the customer experience with their brands. As a result, we’re all learning how to borrow and...

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • (image courtesy of The Times of Northwest Indiana)

      U.S. Steel Updates Layoff Notice to State

      Pittsburgh-based U.S. Steel Corp. (NYSE: X) has updated the State of Indiana regarding its previously announced layoffs at the East Chicago Tin Mill. The company says 314, rather than 307, workers will be displaced when the mill is idled this fall. 

    • Red Star announced plans to expand and add 18 jobs.

      Larwill Medical Device Maker to Expand, Add Jobs

      A Whitley County-based medical device maker has announced plans to expand its facility in Larwill which should mean new jobs. Red Star Contract Manufacturing Inc. says it will invest $1.6 million in real estate improvements and additional equipment and will create 18 new jobs by 2022. 

    • Regal Beloit is closing in Valparaiso. (photo courtesy; The Times of Northwest Indiana)

      Valpo Bearings Plant to Close, Eliminating 160+ Jobs

      Wisconsin-based Regal Beloit Corp. and the union representing workers have reached an agreement about the closing of a helicopter bearing factory in Valparaiso. According to our partners at The Times of Northwest Indiana, the decision will cost between 160 to 170 workers their jobs. 

    • (WISH-TV Photo)

      Clif Bar Expands Indy Bakery

      California-based Clif Bar & Co. has completed a $10 million expansion of its commercial bakery in Indianapolis. The company says the project involved a more sustainable redesign of the facility for its employee-owners with a greater focus on energy efficiency.

    • AM General & Fiat Chrysler announce plans to build military grade Jeep Gladiator pickup trucks.

      AM General, FCA Collaborate on New Military Grade Jeep

      Nearly 80 years since the first jeep rolled off the assembly line, and helped support American soldiers throughout World War II, it appears the trusted four-wheel-drive machine may be making a comeback in the U.S. military. South Bend-based AM General LLC has teamed up with Fiat Chrysler Automobiles to build military-grade versions of the 2020 Jeep Gladiator pickup truck.